Hospital
Hospital Service District No. 3
Hospital Service District No. 3 was paid $3.16M by Medicaid between Jan 2018 and Sep 2019, across 97 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoHOSPITAL SERVICE DISTRICT NO. 3
THIBODAUX, LA 70301
THIBODAUX, LA 70301
33aNPI1275553539assigned 07/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.16M
24GClaims153,998
24DCodes billed97
24AFirst – last monthJan 2018 – Sep 2019
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#57 of 96
Median peer was paid$5.17M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 88,571 | $1.82M | |
| 2019 | 65,427 | $1.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 9,922 | 9,246 | $963K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 13,745 | 13,038 | $951K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.8% | 5,717 | 5,499 | $247K |
| 80053 | Comprehensive metabolic panel | 3.4% | 13,373 | 11,415 | $107K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.4% | 5,537 | 5,019 | $106K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 14,249 | 12,120 | $78K |
| 80050 | General health panel | 2.4% | 1,918 | 1,863 | $75K |
| 71046 | Radiologic examination, chest; 2 views | 1.8% | 1,298 | 1,200 | $57K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 1,941 | 1,718 | $52K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 25,518 | 21,873 | $49K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.5% | 624 | 593 | $46K |
| 83735 | 1.2% | 7,888 | 7,114 | $39K |
85 more codes
| 99285 | Emergency room visit (most serious) | 1.2% | 225 | $37K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 67 | $27K |
| 80061 | Lipid panel | <1% | 2,151 | $26K |
| 87400 | <1% | 3,536 | $25K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 891 | $21K |
| 81025 | <1% | 2,980 | $19K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 312 | $16K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 623 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,499 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,196 | $14K |
| 84484 | <1% | 1,843 | $13K | |
| 83690 | <1% | 2,158 | $12K | |
| 81001 | <1% | 4,588 | $12K | |
| 82553 | <1% | 1,422 | $10K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 55 | $8K |
| 88342 | <1% | 272 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,671 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 500 | $7K |
| 82550 | <1% | 1,674 | $7K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 86 | $7K |
| 43281 | <1% | 12 | $7K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 182 | $5K |
| 84436 | <1% | 1,073 | $5K | |
| 81003 | <1% | 2,611 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 124 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 124 | $5K |
| 82728 | <1% | 305 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 242 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 91 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,502 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 74 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 638 | $3K |
| 43775 | <1% | 44 | $3K | |
| 83550 | <1% | 305 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 217 | $2K |
| 83540 | <1% | 305 | $2K | |
| 84479 | <1% | 335 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 540 | $2K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 16 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 38 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 202 | $1K |
| 87420 | <1% | 102 | $1K | |
| 95806 | <1% | 16 | $1K | |
| 82043 | <1% | 186 | $1K | |
| 82570 | <1% | 187 | $1K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 408 | $973.61 |
| 72110 | <1% | 15 | $970.75 | |
| 84153 | <1% | 45 | $863.52 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 333 | $850.00 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 30 | $821.50 |
| 86140 | <1% | 201 | $813.16 | |
| 94761 | <1% | 43 | $719.27 | |
| 87430 | <1% | 47 | $624.52 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 14 | $539.14 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 43 | $453.28 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 29 | $451.87 |
| C1769 | Guide wire | <1% | 14 | $422.30 |
| 85651 | <1% | 132 | $368.36 | |
| 87081 | <1% | 46 | $309.64 | |
| 87806 | <1% | 12 | $283.14 | |
| 82962 | <1% | 147 | $261.92 | |
| J3490 | Unclassified drugs | <1% | 505 | $253.91 |
| J2704 | Injection, propofol, 10 mg | <1% | 534 | $250.75 |
| 87186 | <1% | 39 | $202.17 | |
| 88300 | <1% | 18 | $190.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 132 | $182.78 |
| J0694 | Injection, cefoxitin sodium, 1 gm | <1% | 173 | $144.62 |
| 83880 | <1% | 12 | $135.29 | |
| 87077 | <1% | 26 | $133.80 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 322 | $121.14 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 171 | $119.81 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 14 | $119.21 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 229 | $94.24 |
| 85027 | <1% | 12 | $86.76 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 539 | $81.70 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 110 | $68.02 |
| 88307 | <1% | 14 | $61.41 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 29 | $54.84 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 27 | $32.32 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 42 | $11.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 26 | $3.51 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 1,073 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 14 | $0.00 |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 0% | 7,404 | $0.00 |
| 72100 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAUBERT, STEVEN (CHIEF FINANCIAL OFFICER)